NGN Capital
NGN Capital is a New York City based venture capital firm focused on investments in healthcare and biotechnology companies in the United States and Europe.
All edits
NGN Capital has invested in Exosome Diagnostics, Endosense, Small Bone Innovations, Artisan Pharma, Noxxon Pharma, Valtech Cardio, BeneChill, Aerovance, Cerapedics and Vivaldi Biosciences.
They exited their investments in Exosome Diagnostics, Small Bone Innovations, Noxxon Pharma, Santhera Pharmaceuticals, Endosense, BeneChill, Valtech Cardio and EKOS Corporation.
NGN Capital
NGN Capital is a New York City based venture capital firm focused on investments in healthcare and biotechnology companies in the United States and Europe.
NGN Capital is a New York City based venture capital firm. They invest in the healthcare and biotechnology companies including drug products, medical devices and healthcare services sectors. NGN Capital focuses their investments on companies they feel have the potential to achieve above average equity returns.
NGN Capital invests across maturity stages, from seed and early stage to later stage, and predominately in the United States and Europe. Their European office is in Heidelberg, Germany.
NGN Capital has invested in Exosome Diagnostics, Endosense, Small Bone Innovations, Artisan Pharma, Noxxon Pharma, Valtech Cardio, BeneChill, Aerovance, Cerapedics and Vivaldi Biosciences.
They exited their investments in Exosome Diagnostics, Small Bone Innovations, Noxxon Pharma, Santhera Pharmaceuticals, Endosense, BeneChill, Valtech Cardio and EKOS Corporation.
NGN Capital
NGN Capital is a New York City based venture capital firm focused on investments in healthcare and biotechnology companies in the United States and Europe.
Find more entities like NGN Capital
